USPTO serial 79443156
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MATTHEW FRISBEE
MATTHEW FRISBEE LEASON ELLIS LLPOne North Lexington Avenue, Suite 1200White Plains, NY 10601United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical modified and unmodified dyes used in scientific research; chemical modified and unmodified dyes used for fluorescent energy transfer in scientific research; oligonucleotides, namely, chemical reagents for use in scientific, diagnostic and pharmaceutical research and other non-clinical applications, other than for medical or veterinary purpose; biochemical reagents used for non-medical purposes comprising a dual-labelled probe for use in scientific, diagnostic and pharmaceutical research and other non-clinical applications | ACTIVE | — |
| 040 | Custom treatment and processing of oligonucleotides, namely, chemical reagents, according to the order and specification of others, for use in scientific, diagnostic and pharmaceutical research and other non-clinical applications; custom treatment and processing of biochemical reagents comprising a dual-labelled probe, according to the order and specification of others, for use in scientific, diagnostic and pharmaceutical research and other non-clinical applications; custom treatment and processing of oligonucleotides, according to the order and specification of others, for use in human and veterinary medical and clinical diagnostic applications; custom treatment and processing of biochemical reagents comprising a dual- labelled probe, according to the order and specification of others, for use in human and veterinary medical and clinical diagnostic applications; custom manufacture of pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 28, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 28, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 26, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 17, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |